Promisia Healthcare Limited logo

Issue of shares

Insider/Shareholder Notice5 November 2019PHLHealthcare

Promisia Ltd
22 Panama St,

Wellington,

New Zealand 6011


DDI +64 4 499 5563

Mobile +64 21 571 000

E rene@promisia.com


PROMISIA.COM



5 November 2019

Issue of Shares following payment in full on exercise of an option to subscribe for shares

(Updated Allotment Notice)

The directors of Promisia Integrative Limited advise that a total of 250,000,000 new shares have

been issued by the company today to the Brankin Trust following the completion of payments to

exercise an option to subscribe for shares.

This transaction was approved by shareholders on 4 December 2018 and the decision by Brankin

Trust to exercise its option was advised to the market on 22 January 2019. Brankin Trust has made

progressive payments to the company over the last 10 months and the sum of $250,000 is now paid

in full and the shares can be issued as fully paid.

The directors thank the Brankin Trust for its support and the provision of funding as the company

awaits resolution of its prosecution by the Ministry of Health.

Please find the Allotment Notice pursuant to Listing Rule 3.13.1 attached.


Stephen Underwood 027 499 3387

---

Template
Capital Change Notice


Updated as at 8 May 2019



Section 1: Issuer information

Name of issuer Promisia Integrative Limited

NZX ticker code PIL

Class of financial product Ordinary Shares

ISIN (If unknown, check on NZX website) NZPRPE0001S5

Currency NZD

Section 2: Capital change details

Number issued/acquired/redeemed 250,000,000 shares issued

Nominal value (if any) Nil

Issue/acquisition/redemption price per security $0.001

Nature of the payment (for example, cash or other

consideration)

Cash

Amount paid up (if not in full) Fully paid

Percentage of total class of Financial Products

issued/acquired/redeemed/ (calculated on the number of

Financial Products of the Class, excluding any Treasury Stock,

in existence)

1


11.62%

For an issue of Convertible Financial Products or Options, the

principal terms of Conversion (for example the Conversion

price and Conversion date and the ranking of the Financial

Product in relation to other Classes of Financial Product) or the

Option (for example, the exercise price and exercise date)

N/A

Reason for issue/acquisition/redemption and specific authority

for issue/acquisition/redemption/ (the reason for change must

be identified here)

Raise working capital.

Resolution of shareholders at

a special meeting of

shareholders held 4 December

2018

Total number of Financial Products of the Class after the

issue/acquisition/redemption/Conversion (excluding Treasury

Stock) and the total number of Financial Products of the Class

held as Treasury Stock after the issue/acquisition/redemption.

2,151,797,451

In the case of an acquisition of shares, whether those shares

are to be held as treasury stock

N/A

Specific authority for the issue, acquisition, or redemption,

including a reference to the rule pursuant to which the issue,

acquisition, or redemption is made

Shareholders approved the

issue of the shares in

compliance with the

requirements of Rules 79 7(c)

and 7(d) of the Takeovers

Code and NZX Listing Rules

7.5.1 (as applicable) and 9.2.1.


1

The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)

The shares were issued

pursuant to an option to

acquire up to 250,000,000

shares at an issue price of

$0.001 per share. The option

was a term of an underwriting

agreement with respect to a

Rights Issue approved by

shareholders on 4 December

2018. The shares could not be

issued until they became fully

paid.

Date of issue/acquisition/redemption

2


04/11/2019


Section 3: Authority for this announcement and contact person

Name of person authorised to make this announcement Stephen Underwood

Contact person for this announcement Stephen Underwood

Contact phone number 027 499 3387

Contact email address stephen@renouf.co.nz

Date of release through MAP 05/11/2019





2

Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant

issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.